{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["NF-\u03baB", "Parkinson\u2019s disease", "SNpc.", "flavonoid", "neuroinflammation", "neuroprotection"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38243959", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "05"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "05"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2174/0113862073295568240105025006"], "ArticleDate": [], "Journal": {"ISSN": "1875-5402", "JournalIssue": {"Volume": "27", "Issue": "14", "PubDate": {"Year": "2024"}}, "Title": "Combinatorial chemistry & high throughput screening", "ISOAbbreviation": "Comb Chem High Throughput Screen"}, "ArticleTitle": "Nuclear Factor Kappa B: A Nobel Therapeutic Target of FlavonoidsAgainst Parkinson's Disease.", "Pagination": {"StartPage": "2062", "EndPage": "2077", "MedlinePgn": "2062-2077"}, "Abstract": {"AbstractText": ["Parkinson's disease (PD), the most common brain-related neurodegenerative disorder, is comprised of several pathophysiological mechanisms, such as mitochondrial dysfunction, neuroinflammation, aggregation of misfolded alpha-synuclein, and synaptic loss in the substantia nigra pars compacta region of the midbrain. Misfolded alpha-synuclein, originating from damaged neurons, triggers a series of signaling pathways in both glial and neuronal cells. Activation of such events results in the production and expression of several proinflammatory cytokines via the activation of the nuclear factor \u03baB (NF-\u03baB) signaling pathway. Consequently, this cascade of events worsens the neurodegenerative processes, particularly in conditions, such as PD and synucleinopathies. Microglia, astrocytes, and neurons are just a few of the many cells and tissues that express the NF-\u03baB family of inducible types of transcription factors. The dual role of NF-\u03baB activation can be crucial for neuronal survival, although the classical NF-\u03baB pathway is important for controlling the generation of inflammatory mediators during neuroinflammation. Modulating NF-\u03baB-associated pathways through the selective action of several agents holds promise for mitigating dopaminergic neuronal degeneration and PD. Several naturally occurring compounds in medicinal plants can be an effective treatment option in attenuating PD-associated dopaminergic neuronal loss via selectively modifying the NF-\u03baB-mediated signaling pathways. Recently, flavonoids have gained notable attention from researchers because of their remarkable anti-neuroinflammatory activity and significant antioxidant properties in numerous neurodegenerative disorders, including PD. Several subclasses of flavonoids, including flavones, flavonols, isoflavones, and anthocyanins, have been evaluated for neuroprotective effects against in vitro and in vivo models of PD. In this aspect, the present review highlights the pathological role of NF-\u03baB in the progression of PD and investigates the therapeutic potential of natural flavonoids targeting the NF-\u03baB signaling pathway for the prevention and management of PD-like manifestations with a comprehensive list for further reference. Available facts strongly support that bioactive flavonoids could be considered in food and/or as lead pharmacophores for the treatment of neuroinflammation-mediated PD. Furthermore, natural flavonoids having potent pharmacological properties could be helpful in enhancing the economy of countries that cultivate medicinal plants yielding bioactive flavonoids on a large scale."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": ["0000-0002-5625-5067"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura-281406, UP, India."}], "LastName": "Singh", "ForeName": "Niraj Kumar", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura-281406, UP, India."}], "LastName": "Singh", "ForeName": "Ashini", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Division of Pharmacology, Institute of Pharmaceutical Research, GLA University, Mathura-281406, UP, India."}], "LastName": "Mayank"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Comb Chem High Throughput Screen", "NlmUniqueID": "9810948", "ISSNLinking": "1386-2073"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["metabolism", "antagonists & inhibitors"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["pharmacology", "chemistry"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kowal S.L.; Dall T.M.; Chakrabarti R.; Storm M.V.; Jain A.; The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 2013,28(3),311-318", "ArticleIdList": ["10.1002/mds.25292", "23436720"]}, {"Citation": "Singh N.K.; Singh A.; Varshney M.; Agrawal R.; A research update on exendin-4 as a novel molecule against parkinson\u2019s disease. Curr Mol Med 2023,23(9),889-900", "ArticleIdList": ["10.2174/1566524023666230529093314", "37254536"]}, {"Citation": "Davie C.A.; A review of Parkinson\u2019s disease. Br Med Bull 2008,86(1),109-127", "ArticleIdList": ["10.1093/bmb/ldn013", "18398010"]}, {"Citation": "Goyal A.; Verma A.; Agrawal A.; Dubey N.; Kumar A.; Behl T.; Therapeutic implications of crocin in Parkinson\u2019s disease: A review of preclinical research. Chem Biol Drug Des 2023,101(6),1229-1240", "ArticleIdList": ["10.1111/cbdd.14210", "36752710"]}, {"Citation": "Surmeier D.J.; Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 2018,285(19),3657-3668", "ArticleIdList": ["10.1111/febs.14607", "30028088"]}, {"Citation": "Bansal K.; Singh S.; Singh V.; Bajpai M.; Nutraceuticals a food for thought in the treatment of parkinson\u2019s disease. Curr Nutr Food Sci 2023,19(9),961-977", "ArticleIdList": ["10.2174/1573401319666230515104325"]}, {"Citation": "Goyal A.; Verma A.; Dubey N.; Raghav J.; Agrawal A.; Naringenin: A prospective therapeutic agent for Alzheimer\u2019s and Parkinson\u2019s disease. J Food Biochem 2022,46(12),e14415", "ArticleIdList": ["10.1111/jfbc.14415", "36106706"]}, {"Citation": "Verma A.; Goyal A.; Reformative effect of daidzein on motor dysfunction following rotenone injection in ovariectomized rats. Rev Bras Farmacogn 2022,32(4),563-574", "ArticleIdList": ["10.1007/s43450-022-00277-3"]}, {"Citation": "Amor S.; Puentes F.; Baker D.; Van Der Valk P.; Inflammation in neurodegenerative diseases. Immunology 2010,129(2),154-169", "ArticleIdList": ["10.1111/j.1365-2567.2009.03225.x", "20561356"]}, {"Citation": "Tufekci K.U.; Meuwissen R.; Genc S.; Genc K.; Inflammation in Parkinson\u2019s disease. Adv Protein Chem Struct Biol 2012,88,69-132", "ArticleIdList": ["10.1016/B978-0-12-398314-5.00004-0", "22814707"]}, {"Citation": "Monahan A.J.; Warren M.; Carvey P.M.; Neuroinflammation and peripheral immune infiltration in Parkinson\u2019s disease: An autoimmune hypothesis. Cell Transplant 2008,17(4),363-372", "ArticleIdList": ["10.3727/096368908784423328", "18522239"]}, {"Citation": "Tansey M.G.; Goldberg M.S.; Neuroinflammation in Parkinson\u2019s disease: Its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis 2010,37(3),510-518", "ArticleIdList": ["10.1016/j.nbd.2009.11.004", "19913097"]}, {"Citation": "Pajares M.I.; Rojo A.; Manda G.; Bosc\u00e1 L.; Cuadrado A.; Inflammation in parkinson\u2019s disease: Mechanisms and therapeutic implications. Cells 2020,9(7),1687", "ArticleIdList": ["10.3390/cells9071687", "32674367"]}, {"Citation": "Church F.C.; Treatment options for motor and non-motor symptoms of parkinson\u2019s disease. Biomolecules 2021,11(4),612", "ArticleIdList": ["10.3390/biom11040612", "33924103"]}, {"Citation": "Karin M.; Lin A.; NF-\u03baB at the crossroads of life and death. Nat Immunol 2002,3(3),221-227", "ArticleIdList": ["10.1038/ni0302-221", "11875461"]}, {"Citation": "Li Q.; Verma I.M.; NF-\u03baB regulation in the immune system. Nat Rev Immunol 2002,2(10),725-734", "ArticleIdList": ["10.1038/nri910", "12360211"]}, {"Citation": "Perkins N.D.; Integrating cell-signalling pathways with NF-\u03baB and IKK function. Nat Rev Mol Cell Biol 2007,8(1),49-62", "ArticleIdList": ["10.1038/nrm2083", "17183360"]}, {"Citation": "Glass C.K.; Saijo K.; Winner B.; Marchetto M.C.; Gage F.H.; Mechanisms underlying inflammation in neurodegeneration. Cell 2010,140(6),918-934", "ArticleIdList": ["10.1016/j.cell.2010.02.016", "20303880"]}, {"Citation": "Mattson M.P.; Camandola S.; NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001,107(3),247-254", "ArticleIdList": ["10.1172/JCI11916", "11160145"]}, {"Citation": "Rocha S.M.; Kirkley K.S.; Chatterjee D.; Aboellail T.A.; Smeyne R.J.; Tjalkens R.B.; Microglia-specific knock-out of NF-\u03baB/IKK2 increases the accumulation of misfolded \u03b1-synuclein through the inhibition of p62/SEQUESTOSOME -1-dependent autophagy in the rotenone model of Parkinson\u2019s disease. Glia 2023,71(9),2154-2179", "ArticleIdList": ["10.1002/glia.24385", "37199240"]}, {"Citation": "Liu T.; Zhang L.; Joo D.; Sun S.C.; NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2017,2(1),17023", "ArticleIdList": ["10.1038/sigtrans.2017.23", "29158945"]}, {"Citation": "Mattson M.P.; Meffert M.K.; Roles for NF-\u03baB in nerve cell survival, plasticity, and disease. Cell Death Differ 2006,13(5),852-860", "ArticleIdList": ["10.1038/sj.cdd.4401837", "16397579"]}, {"Citation": "Salles A.; Romano A.; Freudenthal R.; Synaptic NF-kappa B pathway in neuronal plasticity and memory. J Physiol Paris 2014,108(4-6),256-262", "ArticleIdList": ["10.1016/j.jphysparis.2014.05.002", "24854662"]}, {"Citation": "Dutta D.; Jana M.; Majumder M.; Mondal S.; Roy A.; Pahan K.; Selective targeting of the TLR2/MyD88/NF-\u03baB pathway reduces \u03b1-synuclein spreading in vitro and in vivo. Nat Commun 2021,12(1),5382", "ArticleIdList": ["10.1038/s41467-021-25767-1", "34508096"]}, {"Citation": "Shi Z.M.; Han Y.W.; Han X.H.; Zhang K.; Chang Y.N.; Hu Z.M.; Qi H.X.; Ting C.; Zhen Z.; Hong W.; Upstream regulators and downstream effectors of NF-\u03baB in Alzheimer\u2019s disease. J Neurol Sci 2016,366,127-134", "ArticleIdList": ["10.1016/j.jns.2016.05.022", "27288790"]}, {"Citation": "Srinivasan M.; Lahiri D.K.; Significance of NF-\u03baB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer\u2019s disease and multiple sclerosis. Expert Opin Ther Targets 2015,19(4),471-487", "ArticleIdList": ["10.1517/14728222.2014.989834", "25652642"]}, {"Citation": "Singh S.S.; Rai S.N.; Birla H.; Zahra W.; Rathore A.S.; Singh S.P.; NF-\u03baB-mediated neuroinflammation in Parkinson\u2019s Disease and potential therapeutic effect of polyphenols. Neurotox Res 2020,37(3),491-507", "ArticleIdList": ["10.1007/s12640-019-00147-2", "31823227"]}, {"Citation": "Choy K.W.; Murugan D.; Leong X.F.; Abas R.; Alias A.; Mustafa M.R.; Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NF\u03baB) signaling in cardiovascular diseases: A mini review. Front Pharmacol 2019,10,1295", "ArticleIdList": ["10.3389/fphar.2019.01295", "31749703"]}, {"Citation": "Gasparini L.; Ongini E.; Wenk G.; Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer\u2019s disease: Old and new mechanisms of action. J Neurochem 2004,91(3),521-536", "ArticleIdList": ["10.1111/j.1471-4159.2004.02743.x", "15485484"]}, {"Citation": "Al-Khayri J.M.; Sahana G.R.; Nagella P.; Joseph B.V.; Alessa F.M.; Al-Mssallem M.Q.; Flavonoids as potential anti-inflammatory molecules: A review. Molecules 2022,27(9),2901", "ArticleIdList": ["10.3390/molecules27092901", "35566252"]}, {"Citation": "Kaltschmidt B.; Helweg L.P; Greiner J.F.W.; Kaltschmidt C.; NF-\u03baB in neurodegenerative diseases: Recent evidence from human genetics. Front Mol Neurosci 2022,15,954541", "ArticleIdList": ["10.3389/fnmol.2022.954541", "35983068"]}, {"Citation": "Ghosh G.; Wang V.Y.F.; Huang D.B.; Fusco A.; NF-\u03baB regulation: Lessons from structures. Immunol Rev 2012,246(1),36-58", "ArticleIdList": ["10.1111/j.1600-065X.2012.01097.x", "22435546"]}, {"Citation": "Moynagh P.N.; The NF-\u03baB pathway. J Cell Sci 2005,118(20),4589-4592", "ArticleIdList": ["10.1242/jcs.02579", "16219681"]}, {"Citation": "Gilmore T.D.; Introduction to NF-\u03baB: Players, pathways, perspectives. Oncogene 2006,25(51),6680-6684", "ArticleIdList": ["10.1038/sj.onc.1209954", "17072321"]}, {"Citation": "Cai M.; Zhuang W.; Lv E.; Liu Z.; Wang Y.; Zhang W.; Fu W.; Kaemperfol alleviates pyroptosis and microglia-mediated neuroinflammation in Parkinson\u2019s disease via inhibiting p38MAPK/NF-\u03baB signaling pathway. Neurochem Int 2022,152,105221", "ArticleIdList": ["10.1016/j.neuint.2021.105221", "34780806"]}, {"Citation": "Hoffmann A.; Natoli G.; Ghosh G.; Transcriptional regulation via the NF-\u03baB signaling module. Oncogene 2006,25(51),6706-6716", "ArticleIdList": ["10.1038/sj.onc.1209933", "17072323"]}, {"Citation": "Dolatshahi M.; Ranjbar Hameghavandi M.H.; Sabahi M.; Rostamkhani S.; Nuclear factor-kappa B (NF-\u03baB) in pathophysiology of Parkinson disease: Diverse patterns and mechanisms contributing to neurodegeneration. Eur J Neurosci 2021,54(1),4101-4123", "ArticleIdList": ["10.1111/ejn.15242", "33884689"]}, {"Citation": "Brasier A.R.; The NF-kappaB regulatory network. Cardiovasc Toxicol 2006,6(2),111-130", "ArticleIdList": ["10.1385/CT:6:2:111", "17303919"]}, {"Citation": "Tergaonkar V. NF; \u03baB pathway: A good signaling paradigm and therapeutic target. Int J Biochem Cell Biol 2006,38(10),1647-1653", "ArticleIdList": ["10.1016/j.biocel.2006.03.023", "16766221"]}, {"Citation": "Pomerantz J.L.; Baltimore D.; Two Pathways to NF-\u03ba. B Mol Cell 2002,10(4),693-695", "ArticleIdList": ["10.1016/S1097-2765(02)00697-4", "12419209"]}, {"Citation": "Songkiatisak P.; Rahman, S.M.T.; Aqdas, M.; Sung, M.H. NF-\u03baB, a culprit of both inflamm-ageing and declining immunity? Immun Ageing 2022,19(1),20", "ArticleIdList": ["10.1186/s12979-022-00277-w", "35581646"]}, {"Citation": "Scheidereit C.; I\u03baB kinase complexes: Gateways to NF-\u03baB activation and transcription Oncogene 2006,25(51),6685-6705", "ArticleIdList": ["10.1038/sj.onc.1209934", "17072322"]}, {"Citation": "Panet H.; Barzilai A.; Daily D.; Melamed E.; Offen D.; Activation of nuclear transcription factor kappa B (NF-\u03baB) is essential for dopamine-induced apoptosis in PC12 cells. J Neurochem 2001,77(2),391-398", "ArticleIdList": ["10.1046/j.1471-4159.2001.00213.x", "11299301"]}, {"Citation": "Baiguera C.; Alghisi M.; Pinna A.; Bellucci A.; De Luca M.A.; Frau L.; Morelli M.; Ingrassia R.; Benarese M.; Porrini V.; Pellitteri M.; Bertini G.; Fabene P.F.; Sigala S.; Spillantini M.G.; Liou H.C.; Spano P.F.; Pizzi M.; Late-onset Parkinsonism in NF B/c-Rel-deficient mice. Brain 2012,135(9),2750-2765", "ArticleIdList": ["10.1093/brain/aws193", "22915735"]}, {"Citation": "Parrella E.; Bellucci A.; Porrini V.; Benarese M.; Lanzillotta A.; Faustini G.; Longhena F.; Abate G.; Uberti D.; Pizzi M.; NF-\u03baB/c-Rel deficiency causes Parkinson\u2019s disease-like prodromal symptoms and progressive pathology in mice. Transl Neurodegener 2019,8(1),16", "ArticleIdList": ["10.1186/s40035-019-0154-z", "31139367"]}, {"Citation": "Wang Z.; Dong H.; Wang J.; Huang Y.; Zhang X.; Tang Y.; Li Q.; Liu Z.; Ma Y.; Tong J.; Huang L.; Fei J.; Yu M.; Wang J.; Huang F.; Pro-survival and anti-inflammatory roles of NF-\u03baB c-Rel in the Parkinson\u2019s disease models. Redox Biol 2020,30,101427", "ArticleIdList": ["10.1016/j.redox.2020.101427", "31986466"]}, {"Citation": "Ghosh A.; Roy A.; Liu X.; Kordower J.H.; Mufson E.J.; Hartley D.M.; Ghosh S.; Mosley R.L.; Gendelman H.E.; Pahan K.; Selective inhibition of NF-\u03baB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci 2007,104(47),18754-18759", "ArticleIdList": ["10.1073/pnas.0704908104", "18000063"]}, {"Citation": "Gan L.; Li Z.; Lv Q.; Huang W.; Rabies virus glycoprotein (RVG29)-linked microRNA-124-loaded polymeric nanoparticles inhibit neuroinflammation in a Parkinson\u2019s disease model. Int J Pharm 2019,567,118449", "ArticleIdList": ["10.1016/j.ijpharm.2019.118449", "31226473"]}, {"Citation": "Goes A.T.R.; Jesse C.R.; Antunes M.S.; Lobo Ladd F.V.; Lobo Ladd A.A.B.; Luchese C.; Paroul N.; Boeira S.P.; Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson\u2019s disease: Involvement of neuroinflammation and neurotrophins. Chem Biol Interact 2018,279,111-120", "ArticleIdList": ["10.1016/j.cbi.2017.10.019", "29054324"]}, {"Citation": "Jiang X.; Wang X.; Tuo M.; Ma J.; Xie A.; RAGE and its emerging role in the pathogenesis of Parkinson\u2019s disease. Neurosci Lett 2018,672,65-69", "ArticleIdList": ["10.1016/j.neulet.2018.02.049", "29477598"]}, {"Citation": "Hassanzadeh K.; Rahimmi A.; Oxidative stress and neuroinflammation in the story of Parkinson\u2019s disease: Could targeting these pathways write a good ending? J Cell Physiol 2019,234(1),23-32", "ArticleIdList": ["10.1002/jcp.26865", "30078201"]}, {"Citation": "Asanuma M.; Miyazaki I.; Ogawa N.; Dopamine- or L-DOPA-induced neurotoxicity: The role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease. Neurotox Res 2003,5(3),165-176", "ArticleIdList": ["10.1007/BF03033137", "12835121"]}, {"Citation": "Mi\u00f1ones-Moyano E.; Porta S.; Escaram\u00eds G.; Rabionet R.; Iraola S.; Kagerbauer B.; Espinosa-Parrilla Y.; Ferrer I.; Estivill X.; Mart\u00ed E.; MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum Mol Genet 2011,20(15),3067-3078", "ArticleIdList": ["10.1093/hmg/ddr210", "21558425"]}, {"Citation": "Harraz M.M.; Dawson T.M.; Dawson V.L.; MicroRNAs in Parkinson\u2019s disease. J Chem Neuroanat 2011,42(2),127-130", "ArticleIdList": ["10.1016/j.jchemneu.2011.01.005", "21295133"]}, {"Citation": "Correddu D.; Leung I.K.H.; Targeting mRNA translation in Parkinson\u2019s disease. Drug Discov Today 2019,24(6),1295-1303", "ArticleIdList": ["10.1016/j.drudis.2019.04.003", "30974176"]}, {"Citation": "Mart\u00edn-Nieto J.; Uribe M.L.; Esteve-Rudd J.; Herrero M.T.; Campello L.; A role for DJ-1 against oxidative stress in the mammalian retina. Neurosci Lett 2019,708,134361", "ArticleIdList": ["10.1016/j.neulet.2019.134361", "31276729"]}, {"Citation": "Kabaria S.; Choi D.C.; Chaudhuri A.D.; Mouradian M.M.; Junn E.; Inhibition of miR-34b and miR-34c enhances \u03b1-synuclein expression in Parkinson\u2019s disease. FEBS Lett 2015,589(3),319-325", "ArticleIdList": ["10.1016/j.febslet.2014.12.014", "25541488"]}, {"Citation": "Yao L.; Zhu Z.; Wu J.; Zhang Y.; Zhang H.; Sun X.; Qian C.; Wang B.; Xie L.; Zhang S.; Lu A.G.; MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease. FASEB J 2019,33(7),8648-8665", "ArticleIdList": ["10.1096/fj.201900363R", "30995872"]}, {"Citation": "Wu S.P.; Zhang J.W.; Ma J.J.; Li X.; Qi Y.W.; Yang H.Q.; The role of miR-146a in MPTP treated mice with Parkinson\u2019s disease. Int J Clin Exp Med 2019,12(4),3668-3676"}, {"Citation": "Shah A.; Smith D.L.; Flavonoids in agriculture: Chemistry and roles in, biotic and abiotic stress responses, and microbial associations. Agronomy 2020,10(8),1209", "ArticleIdList": ["10.3390/agronomy10081209"]}, {"Citation": "Chen Y.; Peng F.; Xing Z.; Chen J.; Peng C.; Li D.; Beneficial effects of natural flavonoids on neuroinflammation. Front Immunol 2022,13,1006434", "ArticleIdList": ["10.3389/fimmu.2022.1006434", "36353622"]}, {"Citation": "Schmitt-Schillig S.; Schaffer S.; Weber C.C.; Eckert G.P.; M\u00fcller W.E.; Flavonoids and the aging brain. J Physiol Pharmacol 2005,56(1)(Suppl. 1),23-36", "ArticleIdList": ["15800383"]}, {"Citation": "Ishige K.; Schubert D.; Sagara Y.; Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 2001,30(4),433-446", "ArticleIdList": ["10.1016/S0891-5849(00)00498-6", "11182299"]}, {"Citation": "Bellavite P.; Neuroprotective potentials of flavonoids: Experimental studies and mechanisms of action. Antioxidants 2023,12(2),280", "ArticleIdList": ["10.3390/antiox12020280", "36829840"]}, {"Citation": "Behl T.; Kaur G.; Sehgal A.; Zengin G.; Singh S.; Ahmadi A.; Bungau S.; Flavonoids, the family of plant-derived antioxidants making inroads into novel therapeutic design against ionizing radiation-induced oxidative stress in parkinson\u2019s disease. Curr Neuropharmacol 2022,20(2),324-343", "ArticleIdList": ["10.2174/1570159X19666210524152817", "34030619"]}, {"Citation": "Magalingam K.B.; Radhakrishnan A.K.; Haleagrahara N.; Protective mechanisms of flavonoids in parkinson\u2019s disease. Oxid Med Cell Longev 2015,2015,1-14", "ArticleIdList": ["10.1155/2015/314560", "26576219"]}, {"Citation": "Gao B.; Chang C.; Zhou J.; Zhao T.; Wang C.; Li C.; Gao G.; Pycnogenol protects against rotenone-induced neurotoxicity in PC12 cells through regulating NF-\u03baB-iNOS signaling pathway. DNA Cell Biol 2015,34(10),643-649", "ArticleIdList": ["10.1089/dna.2015.2953", "26203556"]}, {"Citation": "Kumar S.; Pandey A.K.; Chemistry and biological activities of flavonoids: An overview. ScientificWorldJournal 2013,2013,1-16", "ArticleIdList": ["10.1155/2013/162750", "24470791"]}, {"Citation": "Wang Q.; Liu Y.; Zhou J.; Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Transl Neurodegener 2015,4(1),19", "ArticleIdList": ["10.1186/s40035-015-0042-0", "26464797"]}, {"Citation": "Muhammad T.; Ikram M.; Ullah R.; Rehman S.; Kim M.; Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-\u03baB signaling. Nutrients 2019,11(3),648", "ArticleIdList": ["10.3390/nu11030648", "30884890"]}, {"Citation": "Li Y.; Zeng Y.; Meng T.; Gao X.; Huang B.; He D.; Ran X.; Du J.; Zhang Y.; Fu S.; Hu G.; Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson\u2019s disease by suppressing the activation of the AKT and NF-\u03baB signaling pathways. Int Immunopharmacol 2019,75,105739", "ArticleIdList": ["10.1016/j.intimp.2019.105739", "31351366"]}, {"Citation": "Kim D.C.; Quang T.; Oh H.; Kim Y.C.; Steppogenin isolated from cudrania tricuspidata shows antineuroinflammatory effects via NF-\u03baB and MAPK pathways in LPS-Stimulated BV2 and primary rat microglial cells. Molecules 2017,22(12),2130", "ArticleIdList": ["10.3390/molecules22122130", "29207498"]}, {"Citation": "Manach C.; Scalbert A.; Morand C.; R\u00e9m\u00e9sy C.; Jim\u00e9nez L.; Polyphenols: Food sources and bioavailability. Am J Clin Nutr 2004,79(5),727-747", "ArticleIdList": ["10.1093/ajcn/79.5.727", "15113710"]}, {"Citation": "Patel M.; Singh S.; Apigenin attenuates functional and structural alterations via targeting NF-kB/Nrf2 signaling pathway in LPS-induced parkinsonism in experimental rats. Neurotox Res 2022,40(4),941-960", "ArticleIdList": ["10.1007/s12640-022-00521-7", "35608813"]}, {"Citation": "Zhang X.; Yang Y.; Du L.; Zhang W.; Du G.; Baicalein exerts anti-neuroinflammatory effects to protect against rotenone-induced brain injury in rats. Int Immunopharmacol 2017,50,38-47", "ArticleIdList": ["10.1016/j.intimp.2017.06.007", "28623717"]}, {"Citation": "Lee E.; Park H.R.; Ji S.T.; Lee Y.; Lee J.; Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson\u2019s disease model by downregulating the activations of nuclear factor-\u03baB, ERK, and JNK. J Neurosci Res 2014,92(1),130-139", "ArticleIdList": ["10.1002/jnr.23307", "24166733"]}, {"Citation": "Gao X.; He D.; Liu D.; Hu G.; Zhang Y.; Meng T.; Su Y.; Zhou A.; Huang B.; Du J.; Fu S.; Beta-naphthoflavone inhibits LPS-induced inflammation in BV-2 cells via AKT/Nrf-2/HO-1-NF-\u03baB signaling axis. Immunobiology 2020,225(4),151965", "ArticleIdList": ["10.1016/j.imbio.2020.151965", "32747020"]}, {"Citation": "Habib C.N.; Mohamed M.R.; Tadros M.G.; Tolba M.F.; Menze E.T.; Masoud S.I.; The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson\u2019s disease in rats. Eur J Pharmacol 2022,914,174573", "ArticleIdList": ["10.1016/j.ejphar.2021.174573", "34656609"]}, {"Citation": "Qi G.; Mi Y.; Fan R.; Li R.; Liu Z.; Liu X.; Nobiletin protects against systemic inflammation-stimulated memory impairment via MAPK and NF-\u03baB signaling pathways. J Agric Food Chem 2019,67(18),5122-5134", "ArticleIdList": ["10.1021/acs.jafc.9b00133", "30995031"]}, {"Citation": "Meng H.W.; Shen Z.B.; Meng X.S.; Leng-Wei; Yin, Z.Q.; Wang, X.R.; Zou, T.F.; Liu, Z.G.; Wang, T.X.; Zhang, S.; Chen, Y.L.; Yang, X.X.; Li, Q.S.; Duan, Y.J. Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson\u2019s disease via Nrf2/NF-\u03baB signaling pathway. Bioorg Chem 2023,138,106654", "ArticleIdList": ["10.1016/j.bioorg.2023.106654", "37300959"]}, {"Citation": "Zhou X.; Gan P.; Hao L.; Tao L.; Jia J.; Gao B.; Liu J.; Zheng L.T.; Zhen X.; Antiinflammatory effects of orientin-2\u201d-O-galactopyranoside on lipopolysaccharide-stimulated microglia. Biol Pharm Bull 2014,37(8),1282-1294", "ArticleIdList": ["10.1248/bpb.b14-00083", "25087950"]}, {"Citation": "Panche A.N.; Diwan A.D.; Chandra S.R.; Flavonoids: An overview. J Nutr Sci 2016,29,47", "ArticleIdList": ["10.1017/jns.2016.41"]}, {"Citation": "Akinmoladun A.C.; Famusiwa C.D.; Josiah S.S.; Lawal A.O.; Olaleye M.T.; Akindahunsi A.A.; Dihydroquercetin improves rotenone-induced Parkinsonism by regulating NF-\u03baB-mediated inflammation pathway in rats. J Biochem Mol Toxicol 2022,36(5),e23022", "ArticleIdList": ["10.1002/jbt.23022", "35187747"]}, {"Citation": "Josiah S.S.; Famusiwa C.D.; Crown O.O.; Lawal A.O.; Olaleye M.T.; Akindahunsi A.A.; Akinmoladun A.C.; Neuroprotective effects of catechin and quercetin in experimental Parkinsonism through modulation of dopamine metabolism and expression of IL-1\u03b2, TNF-\u03b1, NF-\u03baB, I\u03baKB, and p53 genes in male Wistar rats. Neurotoxicology 2022,90,158-171", "ArticleIdList": ["10.1016/j.neuro.2022.03.004", "35337893"]}, {"Citation": "Iwashina T.; Flavonoid properties of five families newly incorporated into the order Caryophyllales. Bull Natl Mus Nat Sci 2013,39(1),25-51"}, {"Citation": "Zhang F.X.; Xu R.S.; Juglanin ameliorates LPS-induced neuroinflammation in animal models of Parkinson\u2019s disease and cell culture via inactivating TLR4/NF-\u03baB pathway. Biomed Pharmacother 2018,97,1011-1019", "ArticleIdList": ["10.1016/j.biopha.2017.08.132", "29136779"]}, {"Citation": "Lee M.; McGeer E.G.; McGeer P.L.; Quercetin, not caffeine, is a major neuroprotective component in coffee. Neurobiol Aging 2016,46,113-123", "ArticleIdList": ["10.1016/j.neurobiolaging.2016.06.015", "27479153"]}, {"Citation": "Bahar E.; Kim J.Y.; Yoon H.; Quercetin attenuates manganese-induced neuroinflammation by alleviating oxidative stress through regulation of apoptosis, iNOS/NF-\u03baB and HO-1/Nrf2 Pathways. Int J Mol Sci 2017,18(9),1989", "ArticleIdList": ["10.3390/ijms18091989", "28914791"]}, {"Citation": "Notarte K.I.R.; Quimque M.T.J.; Macaranas I.T.; Khan A.; Pastrana A.M.; Villaflores O.B.; Arturo H.C.P.; Pilapil D.Y.H.; Tan S.M.M.; Wei D.Q.; Wenzel-Storjohann A.; Tasdemir D.; Yen C.H.; Ji S.Y.; Kim G.Y.; Choi Y.H.; Macabeo A.P.G.; Attenuation of lipopolysaccharide-induced inflammatory responses through inhibition of the NF-\u03baB Pathway and the Increased NRF2 Level by a Flavonol-Enriched n -Butanol Fraction from Uvaria alba. ACS Omega 2023,8(6),5377-5392", "ArticleIdList": ["10.1021/acsomega.2c06451", "36816691"]}, {"Citation": "Wang Y.H.; Yu H.T.; Pu X.P.; Du G.H.; Myricitrin alleviates methylglyoxal-induced mitochondrial dysfunction and AGEs/RAGE/NF-\u03baB pathway activation in SH-SY5Y cells. J Mol Neurosci 2014,53(4),562-570", "ArticleIdList": ["10.1007/s12031-013-0222-2", "24510749"]}, {"Citation": "Zheng L.T.; Ock J.; Kwon B.M.; Suk K.; Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol 2008,8(3),484-494", "ArticleIdList": ["10.1016/j.intimp.2007.12.012", "18279803"]}, {"Citation": "Zhou J.; Deng Y.; Li F.; Yin C.; Shi J.; Gong Q.; Icariside II attenuates lipopolysaccharide-induced neuroinflammation through inhibiting TLR4/MyD88/NF-\u03baB pathway in rats. Biomed Pharmacother 2019,111,315-324", "ArticleIdList": ["10.1016/j.biopha.2018.10.201", "30590319"]}, {"Citation": "Dias M.C.; Pinto D.C.G.A.; Silva A.M.S.; Plant flavonoids: Chemical characteristics and biological activity. Molecules 2021,26(17),5377", "ArticleIdList": ["10.3390/molecules26175377", "34500810"]}, {"Citation": "Yang J.; Jia M.; Zhang X.; Wang P.; Calycosin attenuates MPTP-induced Parkinson\u2019s disease by suppressing the activation of TLR/NF-\u03baB and MAPK pathways. Phytother Res 2019,33(2),309-318", "ArticleIdList": ["10.1002/ptr.6221", "30421460"]}, {"Citation": "Zhao Y.; Sang Y.; Sun Y.; Wu J.; Pomiferin exerts antineuroinflammatory effects through activating Akt/Nrf2 pathway and inhibiting NF-\u03baB pathway. Mediators Inflamm 2022,2022,1-11", "ArticleIdList": ["10.1155/2022/5824657", "35418806"]}, {"Citation": "Chinta S.J.; Ganesan A.; Reis-Rodrigues P.; Lithgow G.J.; Andersen J.K.; Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide-stimulated microglia: implications for Parkinson\u2019s disease. Neurotox Res 2013,23(2),145-153", "ArticleIdList": ["10.1007/s12640-012-9328-5", "22573480"]}, {"Citation": "Bai Y.; Zhou J.; Zhu H.; Tao Y.; Wang L.; Yang L.; Wu H.; Huang F.; Shi H.; Wu X.; Isoliquiritigenin inhibits microglia-mediated neuroinflammation in models of Parkinson\u2019s disease via JNK / AKT NF\u03ba/B signaling pathway. Phytother Res 2023,37(3),848-859", "ArticleIdList": ["10.1002/ptr.7665", "36484427"]}, {"Citation": "Giusti M.M.; Wrolstad R.E.; Acylated anthocyanins from edible sources and their applications in food systems. Biochem Eng J 2003,14(3),217-225", "ArticleIdList": ["10.1016/S1369-703X(02)00221-8"]}, {"Citation": "Khoo H.E.; Azlan A.; Tang S.T.; Lim S.M.; Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res 2017,61(1),1361779", "ArticleIdList": ["10.1080/16546628.2017.1361779", "28970777"]}, {"Citation": "Khan M.S.; Ali T.; Kim M.W.; Jo M.H.; Chung J.I.; Kim M.O.; Anthocyanins improve hippocampus-dependent memory function and prevent neurodegeneration via JNK/Akt/GSK3\u03b2 signaling in LPS-treated adult mice. Mol Neurobiol 2019,56(1),671-687", "ArticleIdList": ["10.1007/s12035-018-1101-1", "29779175"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "28"}, {"Year": "2023", "Month": "12", "Day": "29"}, {"Year": "2024", "Month": "8", "Day": "5", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "20", "Hour": "21", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "20", "Hour": "10", "Minute": "14"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38243959", "10.2174/0113862073295568240105025006", "CCHTS-EPUB-137508"]}}]}